- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02874053
The Role of Emotions and Regulatory Focus in Decision Making That Involves Risk Tradeoffs
Background:
People with cancer often have to make complex decisions about their treatment. For some of these decisions, they have to weigh the benefits of a treatment against its side effects. They may have to think about its potential to increase the risk of another disease. One example is hormone replacement therapy. That reduces a woman s risk of getting colorectal cancer, but it raises her risk of getting breast cancer. Researchers want to learn more about how people make tradeoff decisions like these.
Objective:
To learn about how people respond to information about hypothetical health and medical treatment options.
Eligibility:
Adults ages 18 70.
Design:
Participants will have one 30-minute visit.
Participants will complete a series of short questionnaires. These will be about their beliefs and values. Some may be about cancer and heart disease risk. Participants ages 18 to 29 will answer questions about sexual health.
Participants will write a paragraph or two about a room in their house or about a life event.
Participants will read a series of stories. These will describe different hypothetical health treatments.
The stories describe a pill that lowers the risk of one health condition, but raises the risk for another. After each story, participants will note how willing they are to take the pill.
Participants will answer questions about the information that they got. They will also answer questions about their health, beliefs, and opinions.
Participants will do 2 attention tasks computer.
Studieoversikt
Status
Forhold
Detaljert beskrivelse
Studietype
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
- INCLUSION CRITERIA:
For Study A, community members will be invited to participate if they are aged 18 to 70.
For Study B, University at Pittsburgh students will be invited to participate if they are aged 18 and over.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
---|
Sunn
Friske Frivillige
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
willingness to take hypothetical pill
Tidsramme: at baseline (cross-sectional)
|
self-reported behavioral willingness
|
at baseline (cross-sectional)
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: William M Klein, National Cancer Institute (NCI)
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Lockwood P, Jordan CH, Kunda Z. Motivation by positive or negative role models: regulatory focus determines who will best inspire us. J Pers Soc Psychol. 2002 Oct;83(4):854-64.
- Waters EA, Weinstein ND, Colditz GA, Emmons KM. Aversion to side effects in preventive medical treatment decisions. Br J Health Psychol. 2007 Sep;12(Pt 3):383-401. doi: 10.1348/135910706X115209.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- 999916161
- 16-C-N161
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .